Evogene Ltd. (EVGN) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to EpoGen's first quarter 2026 results conference call. All participants are at present in listen-only mode. Following management's formal presentation, we will open the question and answer session. You may send questions via chat. Please type your name and company before your question. As a reminder, this conference is being recorded May 20, 2026. Before we begin, I would like to caution that certain statements made during this earning conference call by Avergent's management will constitute forward-looking statements that relate to future events. This presentation contains forward-looking statements relating to future events, and Avergent LTD, the company, may from time to time make other statements regarding our outlook or expectations for future financial or operating results and or other matters regarding or affecting us that are considered forward-looking statements, as defined in the U.S. Private Securities Litigation Reform Act of 1995, the PSLRA, and other security laws as amended. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Such forward-looking statements may be identified by the use of such words as believe, expect, anticipate, should, planned, estimated, intent, and potential, or was of similar meaning. We are using forward-looking statements in this presentation when we discussed our value drivers, commercialization effort and timing, product development and launches, estimated market size and milestones, pipeline, as well as our capabilities and technology. Such statements are based on current expectation, estimates, projections, and assumptions. Described opinions about future events involve certain risks and uncertainties, which are difficult to predict and are not guarantees of future ...